U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 144 results

Status:
US Approved Rx (2019)
First approved in 2002

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist. Olmesartan blocks the vasoconstrictor effects of angiotensin II...
Status:
US Approved Rx (2018)
First approved in 2002

Class (Stereo):
CHEMICAL (ACHIRAL)



The potential antiviral effect of adefovir, an acyclic nucleoside phosphonate analog of 2′-deoxyadenosine monophosphate, was first studied by Holý and De Clercq in 1980s. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is ph...
Status:
US Approved Rx (2010)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



Atomoxetine is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. The precise mechanism by which atomoxetine produces its therapeutic effects in Attention-Deficit/Hyperactivity Disorder (ADHD) is unknown, but is thought to be re...
Status:
US Approved Rx (2019)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



Treprostinil (marketed under the trade names Remodulin for infusion) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Pulmonary arterial hypertension (PAH) is a disease in which blood pressure is abnormally high in ...
Status:
US Approved Rx (2017)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Eletriptan (eletriptan hydrobromide, trade name Relpax) is a selective 5-hydroxytryptamine (5-HT1B/1D) serotonin receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults. Eletriptan binds with high affin...
Status:
US Approved Rx (2015)
First approved in 2002

Class (Stereo):
CHEMICAL (ACHIRAL)



Aripiprazole is the first next-generation atypical antipsychotic. The unique actions of aripiprazole in humans are likely a combination of "functionally selective" activation of D(2) (and possibly D(3))-dopamine receptors and serotonin 5-HT(1A) recep...
Status:
US Approved Rx (2022)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ezetimibe is an anti-hyperlipidemic medication which is used to lower cholesterol levels. Specifically, it appears to bind to a critical mediator of cholesterol absorption, the Niemann-Pick C1-Like 1 (NPC1L1) protein on the gastrointestinal tract epi...
Status:
US Approved Rx (2018)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secr...
Status:
US Approved Rx (2016)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



Voriconazole (vor-i-KON-a-zole, brand name Vfend, Pfizer) is a triazole antifungal medication. VFEND® (voriconazole) is available as film-coated tablets for oral administration, and as a lyophilized powder for solution for intravenous infusion. Vori...
Status:
US Approved Rx (2022)
First approved in 2002

Class (Stereo):
CHEMICAL (EPIMERIC)



Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both b...